Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-178655
Filing Date
2024-07-12
Accepted
2024-07-12 18:23:25
Documents
1
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.MR. AMAURY WITTOUCKSTICHTING ADMINISTRATIEKANTOOR WESTENDWESTEND S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d813236dsc13ga.htm SC 13G/A 133270
  Complete submission text file 0001193125-24-178655.txt   135465
Mailing Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661
Business Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661 352224259-1
Artal International S.C.A. (Filed by) CIK: 0001218180 (see all company filings)

EIN.: 000000000
Type: SC 13G/A

Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1999
Korro Bio, Inc. (Subject) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91158 | Film No.: 241115428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)